IASLC @IASLC · 04 Sep 2026
Congratulations to IASLC Career Advancement Grant awardee @BenCreelan 🎉! His project will survey antigenic targets of T-cell immunity following ERBB2 oncogene-inhibitor therapy. We look forward to seeing the impact of his research! #LungCancerResearch #IASLC https://t.co/wzx9FD9nNN
1 053Views
27Likes
3Reposts
2Replies
0Quotes
0Bookmarks
Is that a lot?
1.32×vs this author's median797 views is typical
71Percentile for this authorof 7 recent posts
0.68×vs 10K–100K median1 540 views is typical
4.99%Reachviews ÷ followers
3.04%Engagement rateof viewers reacted